Sexual function in patients with idiopathic inflammatory myopathies: a cross-sectional study
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
023728
Ministry of Health of the Czech Republic
SVV 260373
Ministry of Education Youth and Sports of the Czech Republic
1578119
Charles University Grant Agency
PubMed
33956947
PubMed Central
PMC8566285
DOI
10.1093/rheumatology/keab397
PII: 6270931
Knihovny.cz E-zdroje
- Klíčová slova
- erectile dysfunction, female sexual dysfunction, idiopathic inflammatory myopathies, sexual health,
- MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- myozitida patofyziologie psychologie MeSH
- pánevní dno patofyziologie MeSH
- průřezové studie MeSH
- senioři MeSH
- sexuální chování fyziologie MeSH
- sexuální zdraví * MeSH
- studie případů a kontrol MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVES: To date, there is almost no information concerning the sexual health of patients with idiopathic inflammatory myopathies (IIM). This cross-sectional study aimed to compare sexual function in patients with IIM to age-/sex-matched healthy controls (HC) and determine the potential impact of clinical features on sexual function. METHODS: In total, 122 women (61 with IIM, 61 age-matched HC) and 22 men (11 with IIM, 11 age-matched HC) aged 18-80 years completed gender-specific selection of 7 well-established and validated questionnaires assessing sexual health and function (Female Sexual Function Index, Brief Index of Sexual Function for Women, Sexual Function Questionnaire, Sexual Quality of Life Questionnaire-Female, International Index of Erectile Function, Male Sexual Health Questionnaire, Sexual Quality of Life Questionnaire-Male). Results were compared between patients and HC and correlated with selected disease-related features. RESULTS: The prevalence of sexual dysfunction in IIM was 59% in women (vs 40% in HC), and 64% (vs 9% in HC) in men. Men and women with IIM reported significantly impaired sexual function compared with sex-/age-matched HC. Decreased sexual function was associated with muscle weakness, disability, physical inactivity, fatigue, depression and decreased quality of life. CONCLUSIONS: Our results suggest that sexual dysfunction is common among IIM patients and more attention should be paid to this aspect of the disease.
Zobrazit více v PubMed
Vencovský J, Alexanderson H, Lundberg IE.. Idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2019;45:569–81. PubMed
Lundberg IE, Miller FW, Tjärnlund A, Bottai M.. Diagnosis and classification of idiopathic inflammatory myopathies. J Intern Med 2016;280:39–51. PubMed PMC
DiRenzo D, Bingham CO, Mecoli CA.. Patient-reported outcomes in adult idiopathic inflammatory myopathies. Curr Rheumatol Rep 2019;21:62. PubMed PMC
Alexanderson H. Exercise in myositis. Curr Treat Options Rheumatol 2018;4:289–98. PubMed PMC
Tristano AG. The impact of rheumatic diseases on sexual function. Rheumatol Int 2009;29:853–60. PubMed
World Health Organization. Defining sexual health: report of a technical consultation on sexual health, 28–31 January 2002. Geneva: World Health Organization, 2006.
Østensen M. Sexual and reproductive health in rheumatic disease. Nat Rev Rheumatol 2017;13:485–93. PubMed
Jaeger VK, Walker UA.. Erectile dysfunction in systemic sclerosis. Curr Rheumatol Rep 2016;18:49. PubMed
Levis B, Hudson M, Knafo R. et al.; Canadian Scleroderma Research Group (CSRG). Rates and correlates of sexual activity and impairment among women with systemic sclerosis. Arthritis Care Res (Hoboken) 2012;64:340–50. PubMed
Merayo-Chalico J, Barrera-Vargas A, Morales-Padilla S. et al. Epidemiologic profile of erectile dysfunction in patients with systemic lupus erythematosus: the Latin American landscape. J Rheumatol 2019;46:397–404. PubMed
Zhang Q, Zhou C, Chen H. et al. Rheumatoid arthritis is associated with negatively variable impacts on domains of female sexual function: evidence from a systematic review and meta-analysis. Psychol Health Med 2018;23:114–25. PubMed
Alemo Munters L, van Vollenhoven RF, Alexanderson H.. Patient preference assessment reveals disease aspects not covered by recommended outcomes in polymyositis and dermatomyositis. Int Scholarly Res Notices 2011;2011:1–5. PubMed PMC
Souza FHC, Araújo DBd, Silva CA. et al. Analysis of sexual function of patients with dermatomyositis and polymyositis through self-administered questionnaires: a cross-sectional study. Rev Bras Reumatol Engl Ed 2017;57:134–40. PubMed
Bohan A, Peter JB.. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344–7. PubMed
Hoogendijk JE, Amato AA, Lecky BR. et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 2004;14:337–45. PubMed
Rose M, ENMC IBM Working Group. 188th ENMC international workshop: inclusion body myositis, 2–4 December 2011, Naarden, The Netherlands. Neuromuscul Disord 2013;23:1044–55. PubMed
Rider LG, Werth VP, Huber AM. et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: physician and patient/parent global activity, manual muscle testing (MMT), health assessment questionnaire (HAQ)/childhood health assessment questionnaire (C‐HAQ), childhood myositis assessment scale (CMAS), myositis disease activity assessment tool (MDAAT), disease activity score (DAS), short form 36 (SF‐36), child health questionnaire (CHQ), physician global damage, myositis damage index (MDI), quantitative muscle testing (QMT), myositis functional index‐2 (FI‐2), myositis activities profile (MAP), inclusion body myositis functional rating scale (IBMFRS), cutaneous dermatomyositis disease area and severity index (CDASI), cutaneous assessment tool (CAT), dermatomyositis skin severity index (dssi), skindex, and dermatology life quality index (DLQI). Arthritis Care Res (Hoboken) 2011;63:S118–S157. PubMed PMC
Miller FW. New approaches to the assessment and treatment of the idiopathic inflammatory myopathies. Ann Rheum Dis 2012;71:i82–i5. PubMed
Rosen CB, Heiman J, Leiblum S. et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191–208. PubMed
Neijenhuijs KI, Hooghiemstra N, Holtmaat K. et al. The Female Sexual Function Index (FSFI)—a systematic review of measurement properties. J Sex Med 2019;16:640–60. PubMed
Wiegel M, Meston C, Rosen R.. The Female Sexual Function Index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005;31:1–20. PubMed
Heřmánková B, Šmucrová H, Mikulášová M. et al. Validation of Czech versions of questionnaires assessing female sexual function and pelvic floor function. Ces Revmatol 2021;29:31–42.
Taylor JF, Rosen RC, Leiblum SR.. Self-report assessment of female sexual function: psychometric evaluation of the Brief Index of Sexual Functioning for Women. Arch Sex Behav 1994;23:627–43. PubMed
Mazer NA, Leiblum SR, Rosen RC.. The brief index of sexual functioning for women (BISF-W): a new scoring algorithm and comparison of normative and surgically menopausal populations. Menopause 2000;7:350–63. PubMed
Quirk FH, Heiman JR, Rosen RC. et al. Development of a sexual function questionnaire for clinical trials of female sexual dysfunction. J Womens Health Gend Based Med 2002;11:277–89. PubMed
Symonds T, Abraham L, Bushmakin AG. et al. Sexual function questionnaire: further refinement and validation. J Sex Med 2012;9:2609–16. PubMed
Quirk F, Haughie S, Symonds T.. The use of the sexual function questionnaire as a screening tool for women with sexual dysfunction. J Sex Med 2005;2:469–77. PubMed
Symonds T, Boolell M, Quirk F.. Development of a questionnaire on sexual quality of life in women. J Sex Marital Ther 2005;31:385–97. PubMed
Rosen RC, Riley A, Wagner G. et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822–30. PubMed
Heřmánková B, Šmucrová H, Mikulášová M. et al. Validation of Czech versions of questionnaires assessing male sexual function and pelvic floor function. Ces Revmatol 2021. Epub ahead of print.
Rosen RC, Catania J, Pollack L. et al. Male Sexual Health Questionnaire (MSHQ): scale development and psychometric validation. Urology 2004;64:777–82. PubMed
Abraham L, Symonds T, Morris MF.. Psychometric validation of a sexual quality of life questionnaire for use in men with premature ejaculation or erectile dysfunction. J Sex Med 2008;5:595–601. PubMed
Rogers RG, Kammerer-Doak D, Villarreal A, Coates K, Qualls C.. A new instrument to measure sexual function in women with urinary incontinence or pelvic organ prolapse. Am J Obstet Gynecol 2001;184:552–8. PubMed
Rogers RG, Coates KW, Kammerer-Doak D, Khalsa S, Qualls C.. A short form of the pelvic organ prolapse/urinary incontinence sexual questionnaire (PISQ-12). Int Urogynecol J 2003;14:164–8. PubMed
Barber M, Walters M, Bump R.. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol 2005;193:103–13. PubMed
Physical Therapy & Beyond. Pelvic Floor Impact Questionnaire – Short Form 7 - Male. 2016. [updated 2016; cited 2021 June 06]. Available from: https://physicaltherapybeyond.com/wp-content/uploads/2016/12/male-pelvic-floor.pdf.
Harna B, Sharma P, Dwivedi D, Sabat D.. Dermatomyositis a diagnostic dilemma: an interesting case series and review of literature. J Clin Exp Dermatol Res 2017;8: 2.
Nazarpour S, Simbar M, Ramezani Tehrani F.. Sexual function in postmenopausal women and serum androgens: a review article. Int J Sex Health 2019;31:244–56.
Stephenson KR, Toorabally N, Lyons L, M. Meston C.. Further validation of the Female Sexual Function Index: specificity and associations with clinical interview data. J Sex Marital Ther 2016;42:448–61. PubMed
McCabe MP, Sharlip ID, Lewis R. et al. Incidence and prevalence of sexual dysfunction in women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015. J Sex Med 2016;13:144–52. PubMed
Di Stasi V, Verde N, Maseroli E. et al. Female sexual dysfunction as a warning sign of chronic disease development. Curr Sex Health Rep 2019;11:307–19.
Shah D. Healthy worker effect phenomenon. Ind J Occup Environ Med 2009;13:77. PubMed PMC